Patents by Inventor Joshua Blight

Joshua Blight has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HPV vaccine
    Patent number: 12064477
    Abstract: The invention relates to a nucleic acid encoding a polypeptide comprising a plurality of conserved peptide sequences, or variants thereof, wherein the conserved sequences are conserved across one or more HPV genotypes 16, 18, 31, 52, 53, and 58; and wherein the polypeptide comprises a conserved peptide sequence of each of the HPV proteins E1, E2, E4, E5, E6, and E7; and associated vaccines, viral vectors, treatment and prophylaxis.
    Type: Grant
    Filed: November 22, 2021
    Date of Patent: August 20, 2024
    Assignee: OXFORD UNIVERSITY INNOVATION LIMITED
    Inventors: Lucy Dorrell, Joshua Blight, Arturo Reyes-Sandoval
  • PARASITE PURIFICATION
    Publication number: 20220204916
    Abstract: The invention relates to parasites, and to methods for purifying a metabolically active obligate parasite of vertebrates and arthropods. The invention is especially concerned with methods of purifying Plasmodium and Theileria parasites, such as P. falciparum and T. parva, and highly motile parasite forms thereof, called sporozoites. The invention also relates to obligate parasites of vertebrates and arthropods purified by the methods of the invention and their use thereof.
    Type: Application
    Filed: May 6, 2020
    Publication date: June 30, 2022
    Applicant: Imperial College Innovations Limited
    Inventors: Andrew Blagborough, Joshua Blight, Arturo Reyes-Sandoval, Katarzyna Sala, Jacob Baum
  • HPV VACCINE
    Publication number: 20220152189
    Abstract: The invention relates to a nucleic acid encoding a polypeptide comprising a plurality of conserved peptide sequences, or variants thereof, wherein the conserved sequences are conserved across one or more HPV genotypes 16, 18, 31, 52, 53, and 58; and wherein the polypeptide comprises a conserved peptide sequence of each of the HPV proteins E1, E2, E4, E5, E6, and E7; and associated vaccines, viral vectors, treatment and prophylaxis.
    Type: Application
    Filed: November 22, 2021
    Publication date: May 19, 2022
    Inventors: Lucy DORRELL, Joshua BLIGHT, Arturo REYES-SANDOVAL
  • HPV vaccine
    Patent number: 11179456
    Abstract: The invention relates to a nucleic acid encoding a polypeptide comprising a plurality of conserved peptide sequences, or variants thereof, wherein the conserved sequences are conserved across one or more HPV genotypes 16, 18, 31, 52, 53, and 58; and wherein the polypeptide comprises a conserved peptide sequence of each of the HPV proteins E1, E2, E4, E5, E6, and E7; and associated vaccines, viral vectors, treatment and prophylaxis.
    Type: Grant
    Filed: August 16, 2018
    Date of Patent: November 23, 2021
    Assignee: OXFORD UNIVERSITY INNOVATION LIMITED
    Inventors: Lucy Dorrell, Joshua Blight, Arturo Reyes-Sandoval
  • HPV VACCINE
    Publication number: 20200306358
    Abstract: The invention relates to a nucleic acid encoding a polypeptide comprising a plurality of conserved peptide sequences, or variants thereof, wherein the conserved sequences are conserved across one or more HPV genotypes 16, 18, 31, 52, 53, and 58; and wherein the polypeptide comprises a conserved peptide sequence of each of the HPV proteins E1, E2, E4, E5, E6, and E7; and associated vaccines, viral vectors, treatment and prophylaxis.
    Type: Application
    Filed: August 16, 2018
    Publication date: October 1, 2020
    Inventors: Lucy DORRELL, Joshua BLIGHT, Arturo REYES-SANDOVAL
  • Dengue vaccines
    Patent number: 10350285
    Abstract: The invention relates to a protein comprising a plurality of conserved peptide sequences, or variants thereof, wherein at least one of the conserved sequences is conserved across all four dengue virus serotypes DENV-1, DENV-2, DENV-3 and DENV-4, and wherein the conserved sequences comprise at least part of a sequence of one or more non-structural proteins of the dengue virus serotypes. The invention further relates to associated peptides, compositions, nucleic acids, viral vectors, virus-like particles, use, prime boost vaccination kits, agents and methods.
    Type: Grant
    Filed: May 11, 2016
    Date of Patent: July 16, 2019
    Assignee: Oxford University Innovation Limited
    Inventors: Arturo Reyes-Sandoval, Cesar Lopez-Camacho, Joshua Blight
  • DENGUE VACCINES
    Publication number: 20180193446
    Abstract: The invention relates to a protein comprising a plurality of conserved peptide sequences, or variants thereof, wherein at least one of the conserved sequences is conserved across all four dengue virus serotypes DENV-1, DENV-2, DENV-3 and DENV-4, and wherein the conserved sequences comprise at least part of a sequence of one or more non-structural proteins of the dengue virus serotypes. The invention further relates to associated peptides, compositions, nucleic acids, viral vectors, virus-like particles, use, prime boost vaccination kits, agents and methods.
    Type: Application
    Filed: May 11, 2016
    Publication date: July 12, 2018
    Applicant: Oxford University Innovation Limited
    Inventors: Arturo Reyes-Sandoval, Cesar Lopez-Camacho, Joshua Blight